Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD

6.21

+0.09 (1.47%)

At close: May 2, 2024, 4:00 PM

6.42

+0.21 (3.38%)

Pre-market: May 3, 2024, 8:28 AM EDT

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	1,916	1,861	604	1,444	1,370	1,442	4,040	-	-	-
Market Cap Growth	-	207.99%	-58.17%	5.42%	-4.98%	-64.31%	-	-	-	-
Enterprise Value	4,568	4,512	3,414	4,063	3,968	4,055	6,512	1,407	1,160	947
PE Ratio	-22.15	-22.15	-4.65	135.93	15.04	-3.98	-193.10	-	-	-
PS Ratio	0.80	0.78	0.27	0.69	0.69	0.89	2.43	-	-	-
PB Ratio	96.87	94.07	2.02	4.01	4.52	6.21	8.00	-	-	-
P/FCF Ratio	6.41	6.23	37.05	7.57	4.32	-31.70	20.99	-	-	-
P/OCF Ratio	5.54	5.38	9.28	5.97	3.61	845.55	16.14	-	-	-
EV/Sales Ratio	1.91	1.89	1.54	1.94	1.99	2.49	3.92	1.36	1.14	1.09
EV/EBITDA Ratio	12.53	12.38	12.40	10.38	10.78	10.22	25.18	11.82	12.38	3.86
EV/EBIT Ratio	33.81	33.40	97.40	25.69	29.90	21.38	53.72	19.26	19.12	4.30
EV/FCF Ratio	15.29	15.10	209.39	21.29	12.51	-89.17	33.83	10.09	-150.72	-75.80
Debt / Equity Ratio	139.05	139.05	9.53	7.98	9.71	11.92	5.33	-3.85	-6.46	-5.19
Debt / EBITDA Ratio	7.55	7.55	10.34	7.35	8.00	6.97	10.41	12.48	12.78	4.12
Debt / FCF Ratio	9.21	9.21	174.49	15.07	9.29	-60.82	13.98	10.65	-155.60	-81.00
Quick Ratio	0.84	0.84	1.03	1.36	1.46	1.38	1.27	1.50	1.97	1.47
Current Ratio	1.63	1.63	1.88	2.25	2.29	2.20	2.32	2.60	3.23	2.53
Asset Turnover	0.66	0.66	0.57	0.53	0.48	0.41	0.58	0.81	0.91	-
Interest Coverage	0.64	0.64	0.22	1.16	0.91	1.13	0.84	1.03	1.10	4.80
Return on Equity (ROE)	-34.90%	-34.90%	-41.00%	3.10%	29.60%	-104.80%	-35.20%	0.00%	0.00%	-
Return on Assets (ROA)	-2.30%	-2.30%	-3.30%	0.30%	2.20%	-9.00%	-0.70%	0.00%	0.00%	-
Return on Capital (ROIC)	6.85%	6.85%	-3.00%	2.30%	2.81%	140.19%	-0.62%	-	-	28.08%
Earnings Yield	-4.38%	-4.51%	-21.52%	0.74%	6.65%	-25.10%	-0.52%	-	-	-
FCF Yield	15.59%	16.06%	2.70%	13.22%	23.15%	-3.15%	4.76%	-	-	-
Buyback Yield / Dilution	-16.69%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%	57.36%	-	-	-
Total Shareholder Return	-16.69%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%	57.36%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).